CPRIT

Brain cancer research draws support

Bioengineer Kevin McHugh wins a Distinguished Scientist Award for brain cancer research from The Sontag Foundation.

Rice facility is ‘one-stop shop’ for customizing DNA to fight cancer

Rice bioengineers, synthetic biologists and cancer researchers celebrated the opening of Rice’s first CPRIT Core Facility, the Genetic Design and Engineering Center, or GDEC, Nov. 10 at the BRC.

Bacterial sensors send a jolt of electricity when triggered

Rice researchers develop programmable bacteria that sense contaminants and release an electronic signal in real time.

Even good gene edits can go bad

A Rice lab leads the effort to reveal threats to the efficacy of gene editing, even when it appears to be working.

RNA-editing tool a fast, sensitive test for COVID-19

Researchers at Rice University and the University of Connecticut modify a gene editing tool to serve as a highly sensitive diagnostic test for the presence of the SARS-CoV-2 virus.

Rice lab grows macroscale, modular materials from bacteria

Rice bioscientists have created bacteria that self-assembles into a material like putty that could soak up pollutants.

Bird’s enzyme points toward novel therapies

Rice University chemists find a rare genetic pathway that helps mammalian cells become drug factories or sensors by synthesizing noncanonical amino acids. The clues came from an uncommon bird.

‘Drug factory’ implants eliminate mesothelioma tumors in mice

Rice and Baylor researchers have used Rice’s “drug factory” implants to eradicate advanced-stage mesothelioma tumors in mice.

Rice models moving ‘washers’ that help DNA replicate

Rice researchers model a key mechanism by which DNA replicates. The study could help identify new targets to treat disease.

Rice, Baylor developing implants to heal heart attack injuries

Rice and Baylor College of Medicine are creating tiny implants that can heal damage from heart attacks.

Rice lab’s ‘drug factory’ implants cleared for human trials

Federal regulators have approved the first human clinical trial of cancer-killing “drug factory” implants created by Rice bioengineers.

Synthetic tools conduct messages from station to station in DNA

Bioengineers used deactivated Cas9 fusion proteins to synthetically control gene expression and reveal new details about natural processes in human cells.

SARS-Arena reveals hidden hooks in virus

SARS-Arena will help to find conserved parts in proteins from SARS-CoV-2 that could be a key for the development of wide-spectrum vaccines.

​​​​​​​Researchers discover new leukemia-killing compounds

Researchers from Rice and MD Anderson Cancer Center have discovered potential new drugs for treating leukemia.

Process to customize molecules does double duty

Chemists develop a method to add two fragments to an alkene molecule in a single process, which could simplify drug and materials design.